246 related articles for article (PubMed ID: 10805736)
1. Neoplastic transformation by Notch requires nuclear localization.
Jeffries S; Capobianco AJ
Mol Cell Biol; 2000 Jun; 20(11):3928-41. PubMed ID: 10805736
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line.
Jeffries S; Robbins DJ; Capobianco AJ
Mol Cell Biol; 2002 Jun; 22(11):3927-41. PubMed ID: 11997524
[TBL] [Abstract][Full Text] [Related]
3. p300 acts as a transcriptional coactivator for mammalian Notch-1.
Oswald F; Täuber B; Dobner T; Bourteele S; Kostezka U; Adler G; Liptay S; Schmid RM
Mol Cell Biol; 2001 Nov; 21(22):7761-74. PubMed ID: 11604511
[TBL] [Abstract][Full Text] [Related]
4. Notch(ic)-ER chimeras display hormone-dependent transformation, nuclear accumulation, phosphorylation and CBF1 activation.
Ronchini C; Capobianco AJ
Oncogene; 2000 Aug; 19(34):3914-24. PubMed ID: 10951584
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic transformation by Notch is independent of transcriptional activation by RBP-J signalling.
Dumont E; Fuchs KP; Bommer G; Christoph B; Kremmer E; Kempkes B
Oncogene; 2000 Jan; 19(4):556-61. PubMed ID: 10698525
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic).
Ronchini C; Capobianco AJ
Mol Cell Biol; 2001 Sep; 21(17):5925-34. PubMed ID: 11486031
[TBL] [Abstract][Full Text] [Related]
7. The notch 3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters.
Beatus P; Lundkvist J; Oberg C; Lendahl U
Development; 1999 Sep; 126(17):3925-35. PubMed ID: 10433920
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2.
Capobianco AJ; Zagouras P; Blaumueller CM; Artavanis-Tsakonas S; Bishop JM
Mol Cell Biol; 1997 Nov; 17(11):6265-73. PubMed ID: 9343387
[TBL] [Abstract][Full Text] [Related]
9. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
Strobl LJ; Höfelmayr H; Marschall G; Brielmeier M; Bornkamm GW; Zimber-Strobl U
J Virol; 2000 Feb; 74(4):1727-35. PubMed ID: 10644343
[TBL] [Abstract][Full Text] [Related]
10. The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity.
Beatus P; Lundkvist J; Oberg C; Pedersen K; Lendahl U
Mech Dev; 2001 Jun; 104(1-2):3-20. PubMed ID: 11404076
[TBL] [Abstract][Full Text] [Related]
11. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway.
Oswald F; Kostezka U; Astrahantseff K; Bourteele S; Dillinger K; Zechner U; Ludwig L; Wilda M; Hameister H; Knöchel W; Liptay S; Schmid RM
EMBO J; 2002 Oct; 21(20):5417-26. PubMed ID: 12374742
[TBL] [Abstract][Full Text] [Related]
12. Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element.
Lu FM; Lux SE
Proc Natl Acad Sci U S A; 1996 May; 93(11):5663-7. PubMed ID: 8643633
[TBL] [Abstract][Full Text] [Related]
13. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway.
Sweeney C; Morrow D; Birney YA; Coyle S; Hennessy C; Scheller A; Cummins PM; Walls D; Redmond EM; Cahill PA
FASEB J; 2004 Sep; 18(12):1421-3. PubMed ID: 15247148
[TBL] [Abstract][Full Text] [Related]
14. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling.
Berezovska O; Jack C; McLean P; Aster JC; Hicks C; Xia W; Wolfe MS; Kimberly WT; Weinmaster G; Selkoe DJ; Hyman BT
J Neurochem; 2000 Aug; 75(2):583-93. PubMed ID: 10899933
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.
Hsieh JJ; Nofziger DE; Weinmaster G; Hayward SD
J Virol; 1997 Mar; 71(3):1938-45. PubMed ID: 9032325
[TBL] [Abstract][Full Text] [Related]
16. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.
Schroeter EH; Kisslinger JA; Kopan R
Nature; 1998 May; 393(6683):382-6. PubMed ID: 9620803
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.
Weng AP; Nam Y; Wolfe MS; Pear WS; Griffin JD; Blacklow SC; Aster JC
Mol Cell Biol; 2003 Jan; 23(2):655-64. PubMed ID: 12509463
[TBL] [Abstract][Full Text] [Related]
18. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
Talora C; Sgroi DC; Crum CP; Dotto GP
Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
[TBL] [Abstract][Full Text] [Related]
19. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain.
Wang J; Shelly L; Miele L; Boykins R; Norcross MA; Guan E
J Immunol; 2001 Jul; 167(1):289-95. PubMed ID: 11418662
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.
Aster JC; Robertson ES; Hasserjian RP; Turner JR; Kieff E; Sklar J
J Biol Chem; 1997 Apr; 272(17):11336-43. PubMed ID: 9111040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
